Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemias

Experimental Hematology

Volumn 39, Issue 2, 2011, Pages

  Capraro, Valérie ^a   Zane, Linda ^a   Poncet, Delphine ^a   Perol, David ^b   Galia, Perrine ^a   Preudhomme, Claude ^c   Bonnefoy Berard, Nathalie ^d   Gilson, Eric ^a   Thomas, Xavier ^e   El Hamri, Mohamed ^e   Chelghoun, Youcef ^e   Michallet, Mauricette ^e   Wattel, Eric ^a,e   Mortreux, Franck ^a   Sibon, David ^a,e  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE LÉON BÉRARD   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; ONCOPROTEIN; PROTEIN GUS; TELOMERASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOGENETICS; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT; TELOMERE;

EID: 78751492768     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.10.008     Document Type: Article

References (27)

1. Okamoto K., Iwano T., Tachibana M., Shinkai Y. Distinct Roles of TRF1 in the Regulation of Telomere Structure and Lengthening. J Biol Chem 2008, 283:23981-23988.
2. Gilson E., Geli V. How telomeres are replicated. Nat Rev Mol Cell Biol 2007, 8:825-838.
3. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100-2110.
4. Deng Y., Chan S.S., Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 2008, 8:450-458.
5. Xu D., Gruber A., Peterson C., Pisa P. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 1998, 102:1367-1375.
6. Hartmann U., Brummendorf T.H., Balabanov S., Thiede C., Illme T., Schaich M. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities. Haematologica 2005, 90:307-316.
7. Swiggers S.J., Kuijpers M.A., de Cort M.J., Beverloo H.B., Zijlmans J.M. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes Cancer 2006, 45:247-256.
8. Cogulu O., Kosova B., Karaca E., et al. Evaluation of telomerase mRNA (hTERT) in childhood acute leukemia. Leuk Lymphoma 2004, 45:2477-2480.
9. Campbell L.J., Fidler C., Eagleton H., et al. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. Leukemia 2006, 20:671-679.
10. Drummond M.W., Hoare S.F., Monaghan A., et al. Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia 2005, 19:381-389.
11. Gabet A.S., Mortreux F., Charneau P., et al. Inactivation of hTERT transcription by Tax. Oncogene 2003, 22:3734-3741.
12. Hara T., Matsumura-Arioka Y., Ohtani K., Nakamura M. Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells. Cancer Sci 2008, 99:1155-1163.
13. Poncet D., Belleville A., t'kint de Roodenbeke C., et al. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia. Blood 2008, 111:2388-2391.
14. Sun J., Huang H., Zhu Y., et al. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Int J Hematol 2005, 82:215-223.
15. Pfaffl M.W., Tichopad A., Prgomet C., Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 2004, 26:509-515.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
17. Kilian A., Bowtell D.D., Abud H.E., et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997, 6:2011-2019.
18. Cogulu O., Kosova B., Gunduz C., et al. The evaluation of hTERT mRNA expression in acute leukemia children and 2 years follow-up of 40 cases. Int J Hematol 2008, 87:276-283.
19. Wang Y., Fang M., Sun X., Sun J. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival. Int J Lab Hematol 2010, 32:230-238.
20. Hsu C.P., Lee L.W., Shai S.E., Chen C.Y. Clinical significance of telomerase and its associate genes expression in the maintenance of telomere length in squamous cell carcinoma of the esophagus. World J Gastroenterol 2005, 11:6941-6947.
21. Lin X., Gu J., Lu C., Spitz M.R., Wu X. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 2006, 12:5720-5725.
22. Nakanishi K., Kawai T., Kumaki F., et al. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Clin Cancer Res 2003, 9:1105-1111.
23. Salhab M., Jiang W.G., Newbold R.F., Mokbel K. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 2008, 109:35-46.
24. Seikaly M.G., Salhab N., Warady B.A., Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol 2007, 22:1195-1204.
25. Biroccio A., Rizzo A., Elli R., et al. TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells. Eur J Cancer 2006, 42:1881-1888.
26. Bechter O.E., Eisterer W., Pall G., Hilbe W., Kuhr T., Thaler J. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 1998, 58:4918-4922.
27. Terrin L., Trentin L., Degan M., et al. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome. Leukemia 2007, 21:965-972.